Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

87.78 -3.24 (-3.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
8 Analysts Have This To Say About Tempus AI
 
Via Benzinga
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
AI Stocks Are Rallying After The Bell: What's Going On?
Several AI-linked stocks are trading higher in Monday's after-hours session after Palantir Technologies shares rocketed higher on the back of blowout earnings. Here's what you need to know. 
Via Benzinga
Topics Artificial Intelligence
Why Tempus Ai Stock Is Skyrocketing Today
Via The Motley Fool
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock
 
Via Benzinga
Topics Artificial Intelligence
Tempus Completes Acquisition of Ambry Genetics
From Tempus AI, Inc.
Via Business Wire
Small- To Mid-Cap Biotech Trades Poised For Gains
On Monday, we called for a trading bottom in healthcare stocks. We also saw momentum picking for two Health Science sectors: small- to mid-cap biotechs, and MedTech. Here is a closer look at these... 
Via Talk Markets
Topics ETFs Stocks / Equities
The Former Speaker Buys AI
TEM is one of the first stocks we can recall that likely rallied significantly because of a Pelosi trade disclosure. 
Via Talk Markets
Topics ETFs Stocks / Equities
Options Corner: Tempus AI Stock Soars On Nancy Pelosi's Call Options — But Should Investors Follow?
Although Nancy Pelosi buying Tempus AI call options is noteworthy, NEM stock is best reserved for advanced volatility traders. 
Via Benzinga
Topics Artificial Intelligence
Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024. 
Via MarketBeat
Topics Artificial Intelligence
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing. 
Via Benzinga
Topics Artificial Intelligence
MarketBeat Week in Review – 01/20 - 01/24
Stocks surged higher as investors reacted positively to dovish tariff news; next week will be highlighted by the Federal Reserve meeting and some tech earnings 
Via MarketBeat
Topics Economy Government World Trade
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now
A regulatory filing from Wednesday night disclosed that Tempus AI founder and CEO Eric Lefkofsky sold 946,084 shares of Tempus between Jan. 15-17. 
Via Stocktwits
Topics Artificial Intelligence
Tempus AI Stock Is Up 40% in January. Is It Too Late to Buy?
Nancy Pelosi disclosed several new stock trades. 
Via The Motley Fool
Topics Artificial Intelligence
What's Going On With Tempus AI Shares Wednesday?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from Tuesday's session. Here's a look at what you need to know. 
Via Benzinga
Topics Artificial Intelligence
Tempus AI: A Game-Changer in AI-Powered Healthcare
TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock. 
Via MarketBeat
Topics Artificial Intelligence
Pelosi Bets Big on AI: This Is What You Need to Know
Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays. 
Via MarketBeat
Topics Artificial Intelligence Government
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
TempusAI Stock Surges On AI-Enabled Healthcare App Launch, Pelosi Buy: Retail Mood Stays Buoyant
TempusAI’s olivia includes features such as smart profile summary, AI-enabled notetaker, medical image sharing, health monitoring and direct data import. 
Via Stocktwits
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Tempus AI Stock Is Trading Higher Tuesday: What's Going On?
Tempus AI Inc (NASDAQ:TEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company. 
Via Benzinga
Topics Artificial Intelligence
Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
From Tempus AI, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia
Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares. 
Via Benzinga
Topics Artificial Intelligence
How HealthCare Industry is Leveraging Artificial Intelligence to Revolutionize Diagnostics and Early Disease Detection
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:TDOC),(NASDAQ:TALK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Tempus Announces the National Launch of FDA-Approved xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care
From Tempus AI, Inc.
Via Business Wire
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.